Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other Cancers

December 15, 2023

https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-and-md-anderson-announce-strategic-alliance-to-advance-rezlidhia-olutasidenib-in-aml-and-other-cancers-302009825.html

Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other Cancers
/PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) and The University of Texas MD Anderson Cancer Center (MD Anderson) today announced a multi-year…
https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-and-md-anderson-announce-strategic-alliance-to-advance-rezlidhia-olutasidenib-in-aml-and-other-cancers-302009825.html

Related news for (RIGL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.